FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.
Peter Marks Drug Administration More Such Health News Biologics Evaluation Da Authorizes Covid 19 Vaccine
Source: rttnews.com